237 related articles for article (PubMed ID: 27206898)
21. Body composition analysis in patients with myotonic dystrophy types 1 and 2.
Peric S; Bozovic I; Nisic T; Banovic M; Vujnic M; Svabic T; Pesovic J; Brankovic M; Basta I; Jankovic M; Savic-Pavicevic D; Rakocevic-Stojanovic V
Neurol Sci; 2019 May; 40(5):1035-1040. PubMed ID: 30790082
[TBL] [Abstract][Full Text] [Related]
22. Quantitative myotonia assessment with a commercially available dynamometer in myotonic dystrophy types 1 and 2.
Horáková M; Horák T; Parmová O; Bednařík J; Voháňka S
Muscle Nerve; 2019 Apr; 59(4):431-435. PubMed ID: 30575988
[TBL] [Abstract][Full Text] [Related]
23. Disease burden of myotonic dystrophy type 1.
Landfeldt E; Nikolenko N; Jimenez-Moreno C; Cumming S; Monckton DG; Gorman G; Turner C; Lochmüller H
J Neurol; 2019 Apr; 266(4):998-1006. PubMed ID: 30788616
[TBL] [Abstract][Full Text] [Related]
24. Personality traits in patients with myotonic dystrophy type 2.
Paunic T; Peric S; Parojcic A; Savic-Pavicevic D; Vujnic M; Pesovic J; Basta I; Lavrnic D; Rakocevic-Stojanovic V
Acta Myol; 2017 Mar; 36(1):14-18. PubMed ID: 28690389
[TBL] [Abstract][Full Text] [Related]
25. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2 : a whole body highfield MRI study.
Kornblum C; Lutterbey G; Bogdanow M; Kesper K; Schild H; Schröder R; Wattjes MP
J Neurol; 2006 Jun; 253(6):753-61. PubMed ID: 16511650
[TBL] [Abstract][Full Text] [Related]
26. Health-related quality of life in patients with myotonic dystrophy type 1 and amyotrophic lateral sclerosis.
Peric' S; Rakocevic-Stojanovic V; Stevic Z; Basta I; Pavlovic S; Vujanac V; Marjanovic L; Lavrnic D
Acta Neurol Belg; 2010 Mar; 110(1):71-7. PubMed ID: 20514929
[TBL] [Abstract][Full Text] [Related]
27. Fatigue and daytime sleepiness rating scales in myotonic dystrophy: a study of reliability.
Laberge L; Gagnon C; Jean S; Mathieu J
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1403-5. PubMed ID: 16170085
[TBL] [Abstract][Full Text] [Related]
28. Towards clinical outcome measures in myotonic dystrophy type 2: a systematic review.
Rastelli E; Montagnese F; Massa R; Schoser B
Curr Opin Neurol; 2018 Oct; 31(5):599-609. PubMed ID: 30048337
[TBL] [Abstract][Full Text] [Related]
29. Review of patient-reported outcome measures for use in myotonic dystrophy type 1 patients.
Symonds T; Randall JA; Campbell P
Muscle Nerve; 2017 Jul; 56(1):86-92. PubMed ID: 27862031
[TBL] [Abstract][Full Text] [Related]
30. Health-Related Quality of Life in Patients with Adult-Onset Myotonic Dystrophy Type 1: A Systematic Review.
Landfeldt E; Edström J; Jimenez-Moreno C; van Engelen BGM; Kirschner J; Lochmüller H
Patient; 2019 Aug; 12(4):365-373. PubMed ID: 30714084
[TBL] [Abstract][Full Text] [Related]
31. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
[TBL] [Abstract][Full Text] [Related]
32. How to capture activities of daily living in myotonic dystrophy type 2?
Montagnese F; Rastelli E; Stahl K; Massa R; Schoser B
Neuromuscul Disord; 2020 Oct; 30(10):796-806. PubMed ID: 32888768
[TBL] [Abstract][Full Text] [Related]
33. Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Bozovic I; Kacar A; Peric S; Nikolic A; Bjelica B; Cobeljic M; Petrovic M; Stojanov A; Djuric V; Stojanovic M; Djordjevic G; Martic V; Dominovic A; Vukojevic Z; Basta I
J Neurol; 2017 Dec; 264(12):2481-2486. PubMed ID: 29086018
[TBL] [Abstract][Full Text] [Related]
34. Clinical, psychosocial, and central correlates of quality of life in myotonic dystrophy type 1 patients.
Laberge L; Mathieu J; Auclair J; Gagnon É; Noreau L; Gagnon C
Eur Neurol; 2013; 70(5-6):308-15. PubMed ID: 24158106
[TBL] [Abstract][Full Text] [Related]
35. Cognitive assessment in patients with myotonic dystrophy type 2.
Peric S; Gunjic I; Delic N; Stojiljkovic Tamas O; Salak-Djokic B; Pesovic J; Petrovic Djordjevic I; Ivanovic V; Savic-Pavicevic D; Meola G; Rakocevic-Stojanovic V
Neuromuscul Disord; 2022 Sep; 32(9):743-748. PubMed ID: 35879188
[TBL] [Abstract][Full Text] [Related]
36. Supraventricular and Ventricular Arrhythmias Are Related to the Type of Myotonic Dystrophy but Not to Disease Duration or Neurological Status.
Bienias P; Łusakowska A; Ciurzyński M; Rymarczyk Z; Irzyk K; Kurnicka K; Kamińska A; Pruszczyk P
Pacing Clin Electrophysiol; 2016 Sep; 39(9):959-68. PubMed ID: 27444982
[TBL] [Abstract][Full Text] [Related]
37. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
Fitzgerald BP; Conn KM; Smith J; Walker A; Parkhill AL; Hilbert JE; Luebbe EA; Moxley RT
J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
[TBL] [Abstract][Full Text] [Related]
38. Cognitive impairment in adult myotonic dystrophies: a longitudinal study.
Sansone V; Gandossini S; Cotelli M; Calabria M; Zanetti O; Meola G
Neurol Sci; 2007 Mar; 28(1):9-15. PubMed ID: 17385090
[TBL] [Abstract][Full Text] [Related]
39. Transcranial brain parenchyma sonographic findings in patients with myotonic dystrophy type 1 and 2.
Mijajlovic M; Bozovic I; Pavlovic A; Rakocevic-Stojanovic V; Gluscevic S; Stojanovic A; Basta I; Meola G; Peric S
Heliyon; 2024 Mar; 10(5):e26856. PubMed ID: 38434309
[TBL] [Abstract][Full Text] [Related]
40. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
